Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan, J Wang… - Journal of thrombosis …, 2011 - Springer
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban-an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan… - Journal of Thrombosis …, 2011 - swepub.kb.se
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan… - … of Thrombosis and …, 2011 - search.proquest.com
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan, J Wang… - 2011 - pubmed.ncbi.nlm.nih.gov
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan, J Wang… - Journal of Thrombosis …, 2011 - infona.pl
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
[引用][C] Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan… - Journal of Thrombosis …, 2011 - cir.nii.ac.jp
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an
oral, direct and selective factor Xa inhibitor | CiNii Research CiNii 国立情報学研究所 学術情報 …
oral, direct and selective factor Xa inhibitor | CiNii Research CiNii 国立情報学研究所 学術情報 …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban-an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan… - Journal of Thrombosis …, 2011 - diva-portal.org
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor.
RC Becker, H Yang, Y Barrett, P Mohan… - … of Thrombosis and …, 2011 - europepmc.org
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
RC Becker, H Yang, Y Barrett, P Mohan, J Wang… - Journal of Thrombosis …, 2011 - infona.pl
An ability to readily determine an anticoagulant effect with an emerging class of direct, active
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …
site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some …